Brookdale Senior Living Company Profile (NYSE:BKD)

Brookdale Senior Living trades on the New York Stock Exchange (NYSE) under the ticker symbol "BKD."

Brookdale Senior Living Inc. (NYSE:BKD) released its quarterly earnings results on Monday, May, 8th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.12) by $0.07. The firm had revenue of $1.22 billion for the quarter, compared to the consensus estimate of $1.21 billion. Brookdale Senior Living had a positive return on equity of 13.22% and a negative net margin of 9.77%. The company's revenue for the quarter was down 3.7% on a year-over-year basis. During the same period last year, the business posted $0.58 EPS. View Brookdale Senior Living's Earnings History.

Brookdale Senior Living is scheduled to release their next quarterly earnings announcement on Monday, August, 7th 2017. View Earnings Estimates for Brookdale Senior Living.

6 equities research analysts have issued 1-year target prices for Brookdale Senior Living's stock. Their predictions range from $12.00 to $29.00. On average, they expect Brookdale Senior Living's stock price to reach $19.33 in the next twelve months. View Analyst Ratings for Brookdale Senior Living.

Here are some recent quotes from research analysts about Brookdale Senior Living stock:

• 1. According to Zacks Investment Research, "Brookdale Senior Living Inc. is a leading owner and operator of senior living facilities throughout the United States. The Company is committed to providing an exceptional living experience through properties that are designed, purpose-built and operated to provide the highest-quality service, care and living accommodations for residents. The Company owns and operates independent, assisted and dementia-care facilities. " (7/10/2017)
• 2. Jefferies Group LLC analysts commented, "We're upgrading BKD to Buy as its risk-reward has improved after its recent pullback. While we're putting a >50% probability that BKD's ongoing sale process results in a deal, we think shares can reach $14.50 even without a takeout if BKD achieves its FCF guidance. That said, combining the Board's recognition of NT fundamental challenges & the compelling LT demographics-driven outlook for senior housing makes a sale of BKD (at $17-$20) more likely, in our view." (3/27/2017)

Some companies that are related to Brookdale Senior Living include Mednax (MD), Masimo Corporation (MASI), Charles River Laboratories International (CRL), PRA Health Sciences (PRAH), Taro Pharmaceutical Industries (TARO), Mallinckrodt PLC (MNK), Exact Sciences Corporation (EXAS), Acadia Healthcare Company (ACHC), PAREXEL International Corporation (PRXL), Hikma Pharmaceuticals Plc (HKMPF), Medidata Solutions (MDSO), Alere (ALR), Bio-Techne Corp (TECH), VWR Corporation (VWR), bluebird bio (BLUE), Integra LifeSciences Holdings Corporation (IART), Neurocrine Biosciences (NBIX) and Akorn (AKRX).

Brookdale Senior Living's management team includes the folowing people:

• Daniel A. Decker, Executive Chairman of the Board
• Thomas Andrew Smith, President, Chief Executive Officer, Director
• Lucinda M. Baier, Chief Financial Officer
• Labeed S. Diab, Chief Operating Officer
• George Thomas Hicks, Executive Vice President - Finance, Treasurer
• Bryan D. Richardson, Executive Vice President, Chief Administrative Officer
• Cedric T. Coco, Executive Vice President, Chief People Officer
• H. Todd Kaestner, Executive Vice President - Corporate Development
• Mary Sue Patchett, Executive Vice President - Community and Field Operations
• Frank M. Bumstead, Independent Director

Brookdale Senior Living's stock is owned by a number of of retail and institutional investors. Top institutional investors include Real Estate Management Services LLC (0.83%), Dalton Greiner Hartman Maher & Co. (0.79%), Oxbow Advisors LLC (0.13%), First Quadrant L P CA (0.13%), Quotient Investors LLC (0.11%) and Bank of Montreal Can (0.10%). Company insiders that own Brookdale Senior Living stock include Daniel A Decker, Frank M Bumstead, George T Hicks, H Todd Kaestner, Jackie M Clegg, Kristin A Ferge, Labeed S Diab, Lucinda M Baier and Thomas Andrew Smith. View Institutional Ownership Trends for Brookdale Senior Living.

Brookdale Senior Living's stock was sold by a variety of institutional investors in the last quarter, including Real Estate Management Services LLC, Dalton Greiner Hartman Maher & Co., Prescott Group Capital Management L.L.C. and Appleton Partners Inc. MA. View Insider Buying and Selling for Brookdale Senior Living.

Brookdale Senior Living's stock was acquired by a variety of institutional investors in the last quarter, including James Investment Research Inc., Bank of Montreal Can, Quantitative Systematic Strategies LLC, Opera Trading Capital, Oxbow Advisors LLC, Aperio Group LLC and First Quadrant L P CA. Company insiders that have bought Brookdale Senior Living stock in the last two years include Daniel A Decker, Frank M Bumstead, George T Hicks, Jackie M Clegg, Labeed S Diab, Lucinda M Baier and Thomas Andrew Smith. View Insider Buying and Selling for Brookdale Senior Living.

Shares of Brookdale Senior Living can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Brookdale Senior Living stock can currently be purchased for approximately $14.30.